The utility of the DDAVP challenge test in children with low von Willebrand factor.
Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. natasha.archer@childrens.harvard.edu.
Natasha M
NM
Archer
Clinical Research Center, Boston Children's Hospital, Boston, MA, USA.
Mihail
M
Samnaliev
Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.
Rachael
R
Grace
Laboratory Medicine, Boston Children's Hospital, Boston, MA, USA.
Carlo
C
Brugnara
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D016896:Treatment Outcome; D014842:von Willebrand Diseases / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy*; D014841:von Willebrand Factor / Q000378:metabolism*
D014841:von Willebrand Factor; D003894:Deamino Arginine Vasopressin
blood coagulation; von Willebrand disease; von Willebrand factor